(Q50629545)

16 March 2018

title

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. (English)

1 reference

16 March 2018

0 references

0 references

1 reference

acute myeloid leukemia

1 reference

8

1 reference

16 March 2018

David C Linch

9

object named as

D C Linch

1 reference

16 March 2018

Rosemary Gale

7

object named as

R E Gale

1 reference

16 March 2018

author name string

D Bowen

1

1 reference

16 March 2018

M J Groves

2

1 reference

16 March 2018

A K Burnett

3

1 reference

16 March 2018

Y Patel

4

1 reference

16 March 2018

C Allen

5

1 reference

16 March 2018

C Green

6

1 reference

16 March 2018

publication date

3 July 2008

1 reference

16 March 2018

published in

Leukemia

1 reference

16 March 2018

volume

23

1 reference

16 March 2018

issue

1

1 reference

16 March 2018

page(s)

203-206

1 reference

16 March 2018

https://scigraph.springernature.com/pub.10.1038/leu.2008.173

exact match

0 references

cites work

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.173

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.173

1 reference

16 March 2018

PubMed ID

18596741

1 reference

16 March 2018